Send the following on WhatsApp
Continue to ChatAstraZeneca 的嚴重氣喘藥物 Tezspire 在韓國獲得市場授權 https://geneonline.news/astrazenecas-severe-asthma-drug-tezspire-has-been-granted-market-authorization-in-south-korea/
AstraZeneca 的嚴重氣喘藥物 Tezspire 在韓國獲得市場授權 https://geneonline.news/astrazenecas-severe-asthma-drug-tezspire-has-been-granted-market-authorization-in-south-korea/